{"transactions":[{"id":1847938,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (Right to Buy)","published_at":"2023-06-21T16:05:12.000Z","date":"2023-06-16","kind":"other","planned":false,"acquired":true,"shares":965130,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by MedAlpha. Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":965130,"derivative":{"exercise_price":0.3854,"exercise_date":"2023-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":965130},"source":{"system":"sec-edgar","filing":"0000899243-23-016125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323016125/doc4.xml","form_type":"4"}},{"id":1847937,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (Right to Buy)","published_at":"2023-06-21T16:05:12.000Z","date":"2023-06-16","kind":"other","planned":false,"acquired":true,"shares":6818181,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT. ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":6818181,"derivative":{"exercise_price":0.3854,"exercise_date":"2023-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":6818181},"source":{"system":"sec-edgar","filing":"0000899243-23-016125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323016125/doc4.xml","form_type":"4"}},{"id":1952323,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (Right to Buy)","published_at":"2023-03-15T16:30:12.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":965130,"price":0.3212,"value":309999.756,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Prior to the Issuer receiving certain required approval of the Issuer's stockholders (the \"Requisite Stockholder Approval\"), the Pre-Funded Warrant holders may only exercise up to the product of (i) the holder's pro rata portion of the Pre-Funded Warrants and (ii) 16,025,925, which is the number of shares equal to 19.99% of the Issuer's Common Stock outstanding on March 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":965130,"derivative":{"exercise_price":0.001,"exercise_date":"2023-03-13","underlying":"Common Stock","underlying_shares":965130},"source":{"system":"sec-edgar","filing":"0000899243-23-008565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323008565/doc4.xml","form_type":"4"}},{"id":1952322,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (Right to Buy)","published_at":"2023-03-15T16:30:12.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":6818181,"price":0.3212,"value":2189999.7372,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Prior to the Issuer receiving certain required approval of the Issuer's stockholders (the \"Requisite Stockholder Approval\"), the Pre-Funded Warrant holders may only exercise up to the product of (i) the holder's pro rata portion of the Pre-Funded Warrants and (ii) 16,025,925, which is the number of shares equal to 19.99% of the Issuer's Common Stock outstanding on March 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":6818181,"derivative":{"exercise_price":0.001,"exercise_date":"2023-03-13","underlying":"Common Stock","underlying_shares":6818181},"source":{"system":"sec-edgar","filing":"0000899243-23-008565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323008565/doc4.xml","form_type":"4"}},{"id":2302652,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":1487058,"price":1.0625,"value":1579999.125,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.\n\nAs a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein."}],"balance_after":1487058,"derivative":{"exercise_price":1.25,"exercise_date":"2022-04-04","expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":1487058},"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302651,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":5571764,"price":1.0625,"value":5919999.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":5571764,"derivative":{"exercise_price":1.25,"exercise_date":"2022-04-04","expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":5571764},"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302650,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":2974117,"price":1.0625,"value":3159999.3125,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.\n\nAs a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein."}],"balance_after":5894897,"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302649,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":11143529,"price":1.0625,"value":11839999.5625,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":15029480,"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2921422,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T16:31:34.000Z","date":"2020-12-31","kind":"purchase","acquired":true,"shares":5727,"price":14.9959,"value":85881.5193,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.83 to $15.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2920780,"source":{"system":"sec-edgar","filing":"0000899243-21-000379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924321000379/doc4.xml","form_type":"4"}},{"id":2921421,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T16:31:34.000Z","date":"2020-12-31","kind":"purchase","acquired":true,"shares":6943,"price":14.9959,"value":104116.5337,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.83 to $15.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3885951,"source":{"system":"sec-edgar","filing":"0000899243-21-000379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924321000379/doc4.xml","form_type":"4"}},{"id":2929005,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-29","kind":"purchase","acquired":true,"shares":45,"price":14,"value":630.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2915053,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929004,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-29","kind":"purchase","acquired":true,"shares":55,"price":14,"value":770.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3879008,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929003,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":3213,"price":13.9766,"value":44906.8158,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.85 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2915008,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929002,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":3894,"price":13.9766,"value":54424.8804,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.85 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3878953,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2931547,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":4019,"price":13.9919,"value":56233.4461,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.90 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2911795,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931546,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":4871,"price":13.9919,"value":68154.5449,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.90 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3875059,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931545,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":9810,"price":13.9865,"value":137207.565,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.91 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2907776,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931544,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":11890,"price":13.9865,"value":166299.485,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.91 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3870188,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931543,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":7661,"price":13.7016,"value":104967.9576,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2897966,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931542,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":9287,"price":13.7016,"value":127246.7592,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3858298,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2934961,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":7358,"price":13.3147,"value":97969.5626,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2890305,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934960,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":8919,"price":13.3147,"value":118753.8093,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3849011,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934959,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-18","kind":"purchase","acquired":true,"shares":8408,"price":13.5946,"value":114303.3968,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.38 to $13.84. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2882947,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934958,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-18","kind":"purchase","acquired":true,"shares":10192,"price":13.5946,"value":138556.1632,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.38 to $13.84. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3840092,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2938127,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":1029,"price":14,"value":14406.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2874539,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938126,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":1248,"price":14,"value":17472.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3829900,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938125,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":5731,"price":13.1201,"value":75191.2931,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.99. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2873510,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938124,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":6946,"price":13.1201,"value":91132.2146,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.99. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3828652,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938123,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-16","kind":"purchase","acquired":true,"shares":12851,"price":13.0611,"value":167848.1961,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2867779,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938122,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-16","kind":"purchase","acquired":true,"shares":15578,"price":13.0611,"value":203465.8158,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3821706,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2942885,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":9027,"price":13.0821,"value":118092.1167,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2854928,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942884,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":10942,"price":13.0821,"value":143144.3382,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3806128,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942883,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":4276,"price":12.4955,"value":53430.758,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.995. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2845901,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942882,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":5184,"price":12.4955,"value":64776.672,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.995. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3795186,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942881,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":6535,"price":12.2443,"value":80016.5005,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.0125 to $12.62. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2841625,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942880,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":7922,"price":12.2443,"value":96999.3446,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.0125 to $12.62. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3790002,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}}]}